GlaxoSmithKline signs a deal to manufacture cut-price HIV drugs in China as the UK group rebuilds its presence after a corruption scandal. Read More...Topics: Business, Health, PoliticsKeywords: Health Care, HIV/AIDS, Pharmaceutical Companies, British-Chinese Relations
